Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by The Beauty Health Company (trading as Skinhealth Systems Inc., ticker: SKIN) on June 12, 2025. The meeting was conducted in a virtual format. As of the record date (April 16, 2025), there were 125,989,795 shares of Class A Common Stock outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Approximately 78.40% of outstanding shares were represented at the meeting, establishing a quorum. The following proposals were voted upon:
- Proposal 1: Election of Directors - Stockholders elected seven directors for one-year terms. While all nominees received majority support, significant votes were withheld for certain candidates:
- Brian Miller: 64,343,799 votes for; 23,595,858 votes withheld.
- Doug Schillinger: 70,559,794 votes for; 17,379,863 votes withheld.
- Desiree Gruber: 69,656,571 votes for; 18,283,086 votes withheld.
- Proposal 2: Ratification of Auditors - Stockholders ratified the appointment of Deloitte & Touche LLP for the fiscal year ending December 31, 2025.
- Votes For: 98,627,630
- Votes Against: 102,141
- Proposal 3: Advisory Vote on Executive Compensation - Stockholders approved the compensation of Named Executive Officers on a non-binding basis.
- Votes For: 67,289,182
- Votes Against: 19,578,688
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the results of the shareholder vote.
Investor Verification Checklist
- Verify the specific reasons for the high number of votes withheld for directors Brian Miller, Doug Schillinger, and Desiree Gruber.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 25, 2025, for detailed descriptions of the proposals and director biographies.
- Confirm the terms of the newly elected directors, which expire at the 2026 annual meeting.
- Check subsequent filings for the Company's financial performance, as this 8-K contains no financial data.